CIRM awards $2mln in G-Rex Grants to 8 CGT manufacturers.

ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady, have awarded eight G-Rex Grants totaling nearly $2 million to awardees of the California Institute for Regenerative Medicine's Manufacturing Network program. The grants aim to enhance operations and establish partnerships with industry and non-profit stakeholders, further establishing California as a world leading hub of cell and gene therapy manufacturing.

ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH), and CellReady, has awarded eight G-Rex Grants totaling nearly $2 million to awardees of the California Institute for Regenerative Medicine's (CIRM) Manufacturing Network program. The grants aim to enhance operations and establish partnerships with industry and non-profit stakeholders, further establishing California as a world-leading hub of cell and gene therapy (CGT) manufacturing [1].

The G-Rex Grants, ranging from $125,000 to $300,000, were awarded to prestigious institutions including UC San Diego, City of Hope, Stanford Medicine, USC/CHLA, UC Davis, UCSF, UCLA, and Cedars Sinai. These grants are part of ScaleReady's $40 million initiative to advance CGT development and manufacturing [2].

The awardees will receive exclusive support from ScaleReady's consortium of G-Rex Grant Partners, offering expertise in cGMP manufacturing, quality control, regulatory affairs, and CGT business operations. This support will help accelerate the development and commercialization of innovative CGT therapies.

References:
[1] https://www.prnewswire.com/news-releases/scaleready-awards-g-rex-grants-to-support-cell-and-gene-therapy-manufacturing-in-california-302548014.html
[2] https://www.stocktitan.net/news/TECH/scale-ready-awards-g-rex-grants-to-support-cell-and-gene-therapy-qejbcphc9d10.html